HYDRAMAX ACTIVE TEINTE SPF 15
Dosage form: lotion
Ingredients: Octinoxate 3.0mL in 40mL, Oxybenzone 0.8mL in 40mL
Labeler: CHANEL PARFUMS BEAUTE
NDC Code: 68745-1141
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
OCTINOXATE 7.5%
OXYBENZONE 2%
FOR EXTERNAL USE ONLY. NOT TO BE SWALLOWED. AVOID CONTACT WITH EYES. IF CONTACT OCCURS, RINSE EYES THOROUGHLY WITH WATER. DISCONTINUE USE IF SIGNS OF IRRITATION APPEAR. IF IRRITATION PERSISTS. CONSULT A DOCTOR. KEEP OUT OF REACH OF CHILDREN. DO NOT USE ON INFANTS UNDER THE AGE OF SIX MONTHS.
SMOOTH ON FACE EACH MORNING.
AQUA (WATER), BUTYLENE GLYCOL, C12-15 ALKYL BENZOATE, GLYCERETH-26, CETYL ALCOHOL, GLYCERYL STEARATE, PROPYLENE GLYCOL, DIMETHICONE, OCTYLDODECYL NEOPENTANOATE, PHENOXYETHANOL, PEG-75 STEARATE, POLYACRYLAMIDE, SACCHARIDE ISOMERATE, JOJOBA ESTERS, PARFUM (FRAGRANCE), CETETH-20, C13-14 ISOPARAFFIN, STEARETH-2, CHLORPHENESIN, HYDROXYPROPYL METHYLCELLULOSE, GLYCERIN, THERMUS THERMOPHILLUS FERMENT, LAURETH-7, CERATONIA SILIQUA (CAROB) FRUIT EXTRACT, SODIUM HYALURONATE, CITRIC ACID, BHT, METHYLPARABEN, POTASSIUM SORBATE, PROPYLPARABEN, ETHYLPARABEN, TOCOPHEROL, BIOTIN [+/-(MAY CONTAIN) CI 77007 (ULTRAMARINES), CI 77491, CI 77492, CI 77499 (IRON OXIDES), CI 77891 (TITANIUM DIOXIDE), MICA]
| HYDRAMAX ACTIVE TEINTE
SPF 15
active moisture tinted lotion lotion |
|||||||||||||
|
|||||||||||||
|
|||||||||||||
|
|||||||||||||
|
|||||||||||||
| Labeler - CHANEL PARFUMS BEAUTE (275137669) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| CHANEL PARFUMS BEAUTE | 277032517 | manufacture | |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.



